Exact Mass: 487.08717260000003
Exact Mass Matches: 487.08717260000003
Found 56 metabolites which its exact mass value is equals to given mass value 487.08717260000003
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pyranocyanin B
Pyranocyanin B is found in fruits. Pyranocyanin B is a constituent of the seeds of Ribes nigrum (blackcurrant) Constituent of the seeds of Ribes nigrum (blackcurrant). Pyranocyanin B is found in fruits.
CAY10575
C22H21N3O6S2 (487.08717260000003)
Pyranocyanin B
(3R)-3-Amino-4-(2,5-difluorophenyl)-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-butanone phosphate (1:1)
C16H19F5N5O5P (487.10439140000005)
5,7-dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid
(8-(benzyloxy)-5-[(1R)-2-broMo-1-{[tert-butyl(diMethyl)silyl]oxy}ethyl]quinolin-2(1H)-one )
2-(4-bromophenyl)-4,6-di(naphthalen-2-yl)-1,3,5-triazine
ethyl 5-(benzyloxy)-6-broMo-2-(3-ethoxy-3-oxopropyl)-1-Methyl-1H-indole-3-carboxylate
C24H26BrNO5 (487.0994246000001)
2-O-benzyl 1-O-tert-butyl (2S,4R)-4-[(4-bromophenyl)methyl]-5-oxopyrrolidine-1,2-dicarboxylate
C24H26BrNO5 (487.0994246000001)
Fulacimstat
C78274 - Agent Affecting Cardiovascular System D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor
cytidine diphosphate choline
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018697 - Nootropic Agents COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Fonazine mesylate
C20H29N3O5S3 (487.12692640000006)
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist
6-bromo-3-[4-oxo-4-[4-(2-pyridinyl)-1-piperazinyl]butyl]-2-sulfanylidene-1H-quinazolin-4-one
C21H22BrN5O2S (487.06774920000004)
2-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5-(dihydrogen phosphate)
C21H22N5O7P (487.12567920000004)
5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[4-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarboxamide
C22H21N3O6S2 (487.08717260000003)
2-[[5-cyano-7-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidin-4-yl]amino]butanedioic acid
Benzenesulfonamide, 4-iodo-N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-
2-pyridin-4-yl-N-[4-(2-thiazolylsulfamoyl)phenyl]-4-quinolinecarboxamide
C24H17N5O3S2 (487.07727719999997)
N-[3-[(3-chlorophenyl)sulfamoyl]-4-methylphenyl]-3-(4-nitrophenyl)-3-oxopropanamide
C22H18ClN3O6S (487.06047980000005)
(E)-3-(4-fluorophenyl)-N-[[4-[(3-methoxypyrazin-2-yl)sulfamoyl]phenyl]carbamothioyl]prop-2-enamide
N-[(1-ethyl-2-oxo-6-benzo[cd]indolyl)sulfonyl]-N-(4-methoxyphenyl)-3-pyridinecarboxamide
C26H21N3O5S (487.12018560000007)
2-[[4-methyl-5-[4-(4-morpholinylsulfonyl)phenyl]-1,2,4-triazol-3-yl]thio]-N-(4-methylphenyl)acetamide
N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-2-{[5-(2-hydroxyphenyl)-4-phenyl-4H-1,2,4-triazol-3-yl]sulfanyl}acetamide
5-Acetyl-2-[2-(6-fluoro-9H-1,3,4,9-tetraaza-fluoren-2-ylsulfanyl)-acetylamino]-4-methyl-thiophene-3-carboxylic acid ethyl ester
4,7-DI(Para-ethoxyphenyl)-6-(ortho-chlorophenyl)-1,2,5-thiadiazolo(3,4-C)pyridine
C27H22ClN3O2S (487.11211820000005)
CDP-choline(1-)
Conjugate base of CDP-choline(1+) arising from deprotonation of the diphosphate function.
SB 271046 (Hydrochloride)
C20H23Cl2N3O3S2 (487.05578280000003)
SB 271046 Hydrochloride (SB 271046A) is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 9.02, 8.55, and 8.81 for rat, pig and human, respectively. SB 271046 Hydrochloride is over 200 fold selective for the 5-HT6 receptor vs 55 other receptors, binding sites and ion channels. Anticonvulsant activity (EC50=0.16 μM)[1].
(1s,2s,5s,8s)-5-[(4s)-2-(1-hydroxy-4-methoxynaphthalen-2-yl)-4,5-dihydro-1,3-thiazol-4-yl]-8,11-dimethyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one
4,4-dichloro-n-{5,5-dichloro-4-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl}-3-methylbutanimidic acid
C18H25Cl4N3O2S (487.04215100000005)
(3s,4s)-8-[(1r)-2-amino-1-hydroxyethyl]-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-3,4-dihydro-2h-1-benzopyran-5-ol
C23H22BrNO6 (487.06304120000004)
2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,4ah,9h,11bh-[1,3]dioxolo[4,5-j]phenanthridine-1,3,4,6,7-pentol
12-(3,4-dihydroxyphenyl)-8,17-dihydroxy-7,16-dimethoxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5(10),6,8,12,14(19),15,17-octaen-3-one
8-(2-amino-1-hydroxyethyl)-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-3,4-dihydro-2h-1-benzopyran-5-ol
C23H22BrNO6 (487.06304120000004)
5-[2-(1-hydroxy-4-methoxynaphthalen-2-yl)-4,5-dihydro-1,3-thiazol-4-yl]-8,11-dimethyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one
(1r,2s,3s,4s,4ar,11br)-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,4h,4ah,9h,11bh-[1,3]dioxolo[4,5-j]phenanthridine-1,3,4,6,7-pentol
7-(3,4-dihydroxyphenyl)-11-hydroxy-3-methyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,8-dioxatricyclo[7.3.1.0⁵,¹³]trideca-3,5(13),6,9,11-pentaen-1-yl
(3s,4r)-8-[(1r)-2-amino-1-hydroxyethyl]-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-3,4-dihydro-2h-1-benzopyran-5-ol
C23H22BrNO6 (487.06304120000004)